YouTube expands medical misinformation policy

YouTube is introducing new policy updates to combat the spread of COVID-19 vaccine misinformation shared on its platform, according to CNBC.

Advertisement

YouTube, which is owned by Google parent company Alphabet, updated its medical misinformation policy Oct. 14 to better contain false claims about COVID-19 vaccines, such as that it will kill people or cause infertility, according to the report.

“In the coming weeks, we will also have more to announce on the work we’re doing to raise authoritative sources on our site related to COVID-19 vaccine content,” the company said, adding that it will take action against false claims about vaccines or ads that discourage vaccines under an existing policy that prohibits contradicts scientific consensus from authoritative sources.

Since February, YouTube has removed more than 200,000 videos related to misleading COVID-19 information, according to the report.

More articles on digital marketing:
4 key considerations for healthcare marketers launching email campaigns
Facebook to ban anti-vaccination ads
6 recently launched healthcare campaigns that used celebrities

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Digital Marketing

Advertisement

Comments are closed.